STOCK TITAN

Bio-Techne Declares Dividend

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
dividends

Rhea-AI Summary

Bio-Techne Corporation (NASDAQ: TECH) announced a quarterly dividend of $0.32 per share for Q3 2021, payable on November 26, 2021. Shareholders of record as of November 12, 2021 will receive this dividend. With approximately $931 million in net sales in fiscal 2021, Bio-Techne continues to support research and clinical diagnostics as a leading provider of innovative tools and bioactive reagents globally.

Loading...
Loading translation...

Positive

  • Quarterly dividend of $0.32 per share increases shareholder income.
  • Strong net sales of approximately $931 million in fiscal 2021 demonstrates robust business performance.

Negative

  • None.
Argus Session date unavailable
-4.14% session move Open Argus
Details

News Market Reaction – TECH

The recorded move for TECH in the trading session of this news was -4.14%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, Nov. 2, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2021. The quarterly dividend will be payable November 26, 2021 to all common shareholders of record on November 12, 2021. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $931 million in net sales in fiscal 2021 and has over 2,600 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.

Contact:

David Clair, Senior Director, Investor Relations & Corporate Development


David.Clair@bio-techne.com


612-656-4416

 

 

Bio-Techne

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-301413746.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the dividend amount declared by Bio-Techne for Q3 2021?

Bio-Techne declared a dividend of $0.32 per share for the quarter ended September 30, 2021.

When will the dividend be paid to shareholders?

The dividend will be payable on November 26, 2021.

What is the record date for the dividend payment?

The record date for the dividend payment is November 12, 2021.

How often does Bio-Techne consider paying dividends?

Bio-Techne's Board of Directors will consider future cash dividends on a quarterly basis.

What were Bio-Techne's net sales in fiscal 2021?

Bio-Techne generated approximately $931 million in net sales in fiscal 2021.

Keep reading